DXR insider transaction filings

DAXOR CORP — 33 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-01. Screen DXR transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 8 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Cremisi Henry D. — Director11
DesRosiers Caleb — Director11
Feldschuh Jonathan Adam — Chief Scientific Officer, Director11
Feldschuh Michael Richard — Chief Executive Officer, Director11
Feuer Edward — Director11
Goudie Joy S. — Director11
Jefferies John — Chief Medical Officer11
Michel Robert J — Chief Financial Officer11

Recent Form 4 filings — DAXOR CORP

FiledFormInsiderReported transactionsSource
2026-09-014Jefferies John — Chief Medical OfficerGrant/award (A): 2,451 @ $0EDGAR
2026-06-254DesRosiers Caleb — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2026-06-254Goudie Joy S. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2026-06-254Cremisi Henry D. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2026-06-254Feldschuh Jonathan Adam — Chief Scientific Officer, DirectorGrant/award (A): 25,000 @ $0EDGAR
2026-06-254Feuer Edward — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2026-06-254Feldschuh Michael Richard — Chief Executive Officer, DirectorGrant/award (A): 30,000 @ $0EDGAR
2026-06-254Michel Robert J — Chief Financial OfficerGrant/award (A): 12,000 @ $0EDGAR
2026-04-104Feldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 1,000 @ $9.07EDGAR
2026-03-314Michel Robert J — Chief Financial OfficerPurchase (P): 1,000 @ $9.90EDGAR
2026-03-244Jefferies John — Chief Medical OfficerPurchase (P): 3,656 @ $0 · Purchase (P): 2,285 @ $0EDGAR
2025-12-114Feldschuh Jonathan Adam — Chief Scientific Officer, DirectorPurchase (P): 18,000 @ $0EDGAR
2025-12-114Michel Robert J — Chief Financial OfficerPurchase (P): 3,000 @ $0EDGAR
2025-11-144Jefferies John — Chief Medical OfficerPurchase (P): 2,344 @ $0EDGAR
2025-06-264DesRosiers Caleb — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2025-06-264Goudie Joy S. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2025-06-264Cremisi Henry D. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2025-06-264Feuer Edward — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2025-04-074Feldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 2,063 @ $7.89EDGAR
2025-03-274Feldschuh Michael Richard — Chief Executive Office, DirectorPurchase (P): 1,000 @ $8.13EDGAR
2025-03-204Feldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 647 @ $8.15EDGAR
2025-03-204/AFeldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 1,492 @ $7.72EDGAR
2025-03-114Feldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 3,360 @ $7.68EDGAR
2025-03-114Michel Robert J — Chief Financial OfficerPurchase (P): 1,000 @ $8EDGAR
2024-12-104Feldschuh Jonathan Adam — Chief Scientific Officer, DirectorPurchase (P): 32,000 @ $0EDGAR
2024-12-104Feldschuh Michael Richard — Chief Executive Officer, DirectorPurchase (P): 45,000 @ $0EDGAR
2024-12-104Michel Robert J — Chief Financial OfficerPurchase (P): 4,750 @ $0EDGAR
2024-07-174DesRosiers Caleb — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-07-174Goudie Joy S. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-07-174Cremisi Henry D. — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-07-174Feuer Edward — DirectorGrant/award (A): 2,500 (derivative) @ $0EDGAR
2024-03-274Michel Robert J — Chief Financial OfficerPurchase (P): 750 @ $8.70EDGAR
2024-03-064Feuer Edward — DirectorPurchase (P): 1,000 @ $7.21EDGAR

Recent 8-K events — DAXOR CORP

FiledFormItems reportedSource
2026-06-248-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-01-268-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-018-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-07-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-06-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2024-03-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-028-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DXR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →